{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T01:32:38Z","timestamp":1785461558860,"version":"3.56.0"},"reference-count":38,"publisher":"Sociedade Brasileira de Pneumologia e Tisiologia","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bras Pneumol."],"abstract":"<jats:p>Objective: To evaluate the incidence rates of mycobacterial infections in silicosis patients with systemic autoimmune rheumatic disease (ARD). Methods: This was a retrospective cohort of silicosis patients between January of 1999 and December of 2023. We compared the incidence of tuberculosis and nontuberculous mycobacterial disease (NTM) in patients with silicosis with and without ARD. We also compared the tuberculosis incidence in the overall cohort with general Brazilian population estimates. Results: The study comprised 369 silicosis patients, of whom 35 (9.5%) had ARD. Having ARD did not affect the cumulative incidence of mycobacterial diseases. The risk of tuberculosis was higher in the cohort when compared with that in the adult Brazilian male population (age-adjusted incidence rate ratio = 20.46; 95% CI 14.89-28.13). Conclusions: In this cohort of patients with silicosis, ARD was not associated with the incidence of mycobacterial diseases.<\/jats:p>","DOI":"10.36416\/1806-3756\/e20240265","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T21:58:58Z","timestamp":1731448738000},"page":"e20240265","source":"Crossref","is-referenced-by-count":3,"title":["Risk of mycobacterial infections in a cohort of silicosis patients with autoimmune rheumatic diseases"],"prefix":"10.36416","author":[{"given":"Rafael","family":"Futoshi Mizutani1","sequence":"first","affiliation":[{"name":"1. Divis\u00e3o de Pneumologia, Instituto do Coracao - InCor - Hospital das Clinicas -HCFMUSP - Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ubiratan","family":"Paula Santos1","sequence":"additional","affiliation":[{"name":"1. Divis\u00e3o de Pneumologia, Instituto do Coracao - InCor - Hospital das Clinicas -HCFMUSP - Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta Karla","family":"Barbosa Sales1","sequence":"additional","affiliation":[{"name":"1. Divis\u00e3o de Pneumologia, Instituto do Coracao - InCor - Hospital das Clinicas -HCFMUSP - Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Figueiredo Neves Yuki2","sequence":"additional","affiliation":[{"name":"2. Divis\u00e3o de Reumatologia, Hospital das Clinicas -HCFMUSP - Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa Maria","family":"Siqueira Lombardi1","sequence":"additional","affiliation":[{"name":"1. Divis\u00e3o de Pneumologia, Instituto do Coracao - InCor - Hospital das Clinicas -HCFMUSP - Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavinia","family":"Clara del Roio1","sequence":"additional","affiliation":[{"name":"1. Divis\u00e3o de Pneumologia, Instituto do Coracao - InCor - Hospital das Clinicas -HCFMUSP - Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Terra-Filho1","sequence":"additional","affiliation":[{"name":"1. Divis\u00e3o de Pneumologia, Instituto do Coracao - InCor - Hospital das Clinicas -HCFMUSP - Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo (SP) Brasil."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"22288","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1.           Calvert GM, Rice FL, Boiano JM, Sheehy JW, Sanderson WT. Occupational silica exposure and risk of various diseases: an analysis using death certificates from 27 states of the United States. Occup Environ Med. 2003;60(2):122-129. https:\/\/doi.org\/10.1136\/oem.60.2.122","DOI":"10.1136\/oem.60.2.122"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"2.           Boudigaard SH, Schl\u00fcnssen V, Vestergaard JM, S\u00f8ndergaard K, Tor\u00e9n K, Peters S, et al. Occupational exposure to respirable crystalline silica and risk of autoimmune rheumatic diseases: a nationwide cohort study. Int J Epidemiol. 2021;50(4):1213-1226. https:\/\/doi.org\/10.1093\/ije\/dyaa287","DOI":"10.1093\/ije\/dyaa287"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"3.           Makol A, Reilly MJ, Rosenman KD. Prevalence of connective tissue disease in silicosis (1985-2006)-a report from the state of Michigan surveillance system for silicosis. Am J Ind Med. 2011;54(4):255-262. https:\/\/doi.org\/10.1002\/ajim.20917","DOI":"10.1002\/ajim.20917"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4.           Freire M, Alonso M, Rivera A, Sousa A, Soto A, G\u00f3mez-Sousa JM, et al. Clinical peculiarities of patients with scleroderma exposed to silica: A systematic review of the literature. Semin Arthritis Rheum. 2015;45(3):294-300. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.06.004","DOI":"10.1016\/j.semarthrit.2015.06.004"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5.           Conrad K, Mehlhorn J, L\u00fcthke K, D\u00f6rner T, Frank KH. Systemic lupus erythematosus after heavy exposure to quartz dust in uranium mines: clinical and serological characteristics. Lupus. 1996;5(1):62-69. https:\/\/doi.org\/10.1177\/096120339600500112","DOI":"10.1177\/096120339600500112"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6.           Tervaert JW, Stegeman CA, Kallenberg CG. Silicon exposure and vasculitis. Curr Opin Rheumatol. 1998;10(1):12-17. https:\/\/doi.org\/10.1097\/00002281-199801000-00003","DOI":"10.1097\/00002281-199801000-00003"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"7.           Corbett EL, Churchyard GJ, Clayton T, Herselman P, Williams B, Hayes R, et al. Risk factors for pulmonary mycobacterial disease in South African gold miners. A case-control study. Am J Respir Crit Care Med. 1999;159(1):94-99. https:\/\/doi.org\/10.1164\/ajrccm.159.1.9803048","DOI":"10.1164\/ajrccm.159.1.9803048"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"8.           Cowie RL. The epidemiology of tuberculosis in gold miners with silicosis. Am J Respir Crit Care Med. 1994;150(5 Pt 1):1460-1462. https:\/\/doi.org\/10.1164\/ajrccm.150.5.7952577","DOI":"10.1164\/ajrccm.150.5.7952577"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"9.           Lai CC, Lee MT, Lee SH, Lee SH, Chang SS, Lee CC. Risk of incident active tuberculosis and use of corticosteroids. Int J Tuberc Lung Dis. 2015;19(8):936-942. https:\/\/doi.org\/10.5588\/ijtld.15.0031","DOI":"10.5588\/ijtld.15.0031"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10.        Bryant PA, Baddley JW. Opportunistic Infections in Biological Therapy, Risk and Prevention. Rheum Dis Clin North Am. 2017;43(1):27-41. https:\/\/doi.org\/10.1016\/j.rdc.2016.09.005","DOI":"10.1016\/j.rdc.2016.09.005"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11.        Arakawa H, Honma K, Shida H, Saito Y, Morikubo H. Computed tomography findings of Caplan syndrome. J Comput Assist Tomogr. 2003;27(5):758-760. https:\/\/doi.org\/10.1097\/00004728-200309000-00013","DOI":"10.1097\/00004728-200309000-00013"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"12.        Goyal A, Madan K, Singh N. Erasmus syndrome with pulmonary tuberculosis. BMJ Case Rep. 2013;2013:bcr2013010443. https:\/\/doi.org\/10.1136\/bcr-2013-010443","DOI":"10.1136\/bcr-2013-010443"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"13.        Sharma RK, Gupta M, Sharma AK. Pulmonary tuberculosis in association with Erasmus syndrome. Indian J Dermatol Venereol Leprol. 2020;86(3):292-295. https:\/\/doi.org\/10.4103\/ijdvl.IJDVL_187_18","DOI":"10.4103\/ijdvl.ijdvl_187_18"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"14.        Stratta P, Messuerotti A, Canavese C, Coen M, Luccoli L, Bussolati B, et al. The role of metals in autoimmune vasculitis: epidemiological and pathogenic study. Sci Total Environ. 2001;270(1-3):179-190. https:\/\/doi.org\/10.1016\/S0048-9697(00)00800-7","DOI":"10.1016\/s0048-9697(00)00800-7"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15.        Mizutani RF, Lombardi EMS, Santos UDP, Terra-Filho M. Silica exposure, silicosis, autoimmune diseases, tuberculosis and nontuberculous pulmonary mycobacterial disease. Eur Respir J; 2016(48):PA1171. 10.1183\/13993003.congress-2016.PA1171 https:\/\/doi.org\/10.1183\/13993003.congress-2016.PA1171","DOI":"10.1183\/13993003.congress-2016.pa1171"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"16.        Chong S, Lee KS, Chung MJ, Han J, Kwon OJ, Kim TS. Pneumoconiosis: comparison of imaging and pathologic findings. Radiographics. 2006;26(1):59-77. https:\/\/doi.org\/10.1148\/rg.261055070","DOI":"10.1148\/rg.261055070"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"17.        Kay J, Upchurch KS. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford). 2012;51 Suppl 6:vi5-vi9. https:\/\/doi.org\/10.1093\/rheumatology\/kes279","DOI":"10.1093\/rheumatology\/kes279"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18.        van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72(11):1747-1755. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204424","DOI":"10.1136\/annrheumdis-2013-eular.238"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"19.        Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(9):1400-1412. https:\/\/doi.org\/10.1002\/art.40930","DOI":"10.1002\/acr.24078"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"20.        Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. https:\/\/doi.org\/10.1002\/art.37715","DOI":"10.1007\/978-3-319-40136-2_3"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21.        Mosca M, Tani C, Vagnani S, Carli L, Bombardieri S. The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun. 2014;48-49:50-52. https:\/\/doi.org\/10.1016\/j.jaut.2014.01.019","DOI":"10.1016\/j.jaut.2014.01.019"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22.        World Health Organization [homepage on the Internet]. Geneva: WHO; c2024; [cited 2024 Jul 12]. WHO operational handbook on tuberculosis - Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection, third edition. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240089501","DOI":"10.2471\/b09117"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23.        Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [published correction appears in Am J Respir Crit Care Med. 2007 Apr 1;175(7):744-5. Dosage error in article text]. Am J Respir Crit Care Med. 2007;175(4):367-416. https:\/\/doi.org\/10.1164\/rccm.200604-571ST","DOI":"10.1164\/rccm.200604-571st"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24.        Instituto Brasileiro de Geografia e Estat\u00edstica (IBGE) [homepage on the Internet]. Rio de Janeiro: IBGE); ]. [cited 2024 Jul 12]. Proje\u00e7\u00f5es da Popula\u00e7\u00e3o. Available from: https:\/\/www.ibge.gov.br\/estatisticas\/sociais\/populacao\/9109-projecao-da-populacao.html","DOI":"10.17143\/ciaed\/xxiilciaed.2017.00322"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"25.        Brasil. Minist\u00e9rio da Sa\u00fade. Secretaria de Vigil\u00e2ncia em Sa\u00fade. Departamento de Inform\u00e1tica do SUS (DATASUS) [homepage on the Internet]. Bras\u00edlia: DATASUS; [cited 2024 Jul 12]. Sistema de Informa\u00e7\u00e3o de Agravos de Notifica\u00e7\u00e3o (SINAN). Casos de Tuberculose - Desde 2001. Available from: https:\/\/datasus.saude.gov.br\/acesso-a-informacao\/casos-de-tuberculose-desde-2001-sinan\/","DOI":"10.1590\/2317-6369000116915"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26.        Carneiro MDS, Nunes LS, David SMM, Dias CF, Barth AL, Unis G. Nontuberculous mycobacterial lung disease in a high tuberculosis incidence setting in Brazil. J Bras Pneumol. 2018;44(2):106-111. https:\/\/doi.org\/10.1590\/s1806-37562017000000213","DOI":"10.1590\/s1806-37562017000000213"},{"key":"ref26","unstructured":"27.        Senna ER, De Barros ALP, Silva EO, Costa IF, Pereira LVB, Ciconelli RM, et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol. 2004;31(3):594-597."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"28.        Horimoto AMC, Matos ENN, Costa MRD, Takahashi F, Rezende MC, Kanomata LB, et al. Incidence and prevalence of systemic sclerosis in Campo Grande, State of Mato Grosso do Sul, Brazil. Rev Bras Reumatol Engl Ed. 2017;57(2):107-114. https:\/\/doi.org\/10.1016\/j.rbr.2016.05.008","DOI":"10.1016\/j.rbre.2016.09.005"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29.        Blanco P\u00e9rez JJ, Arnalich Montiel V, Salgado-Barreira \u00c1, Alvarez Moure MA, Caldera D\u00edaz AC, Melero Gonzalez R, et al. Prevalence and clinical impact of systemic autoimmune rheumatic disease in patients with silicosis. Arch Bronconeumol. 2021;57(9):571-576. https:\/\/doi.org\/10.1016\/j.arbres.2020.04.012","DOI":"10.1016\/j.arbr.2021.06.003"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"30.        Shtraichman O, Blanc PD, Ollech JE, Fridel L, Fuks L, Fireman E, et al. Outbreak of autoimmune disease in silicosis linked to artificial stone. Occup Med (Lond). 2015;65(6):444-450. https:\/\/doi.org\/10.1093\/occmed\/kqv073","DOI":"10.1093\/occmed\/kqv073"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"31.        Rose C, Heinzerling A, Patel K, Sack C, Wolff J, Zell-Baran L, et al. Severe Silicosis in Engineered Stone Fabrication Workers - California, Colorado, Texas, and Washington, 2017-2019. MMWR Morb Mortal Wkly Rep. 2019;68(38):813-818. https:\/\/doi.org\/10.15585\/mmwr.mm6838a1","DOI":"10.15585\/mmwr.mm6838a1"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32.        Pollard KM. Silica, Silicosis, and Autoimmunity. Front Immunol. 2016;7:97. https:\/\/doi.org\/10.3389\/fimmu.2016.00097","DOI":"10.3389\/fimmu.2016.00097"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33.        Brasil. Minist\u00e9rio da Sa\u00fade [homepage on the Internet]. Bras\u00edlia: Minist\u00e9rio da Sa\u00fade; c2024 [cited 2024 Jul 12]. Boletim Epidemiol\u00f3gico de Tuberculose - N\u00famero Especial: Mar. 2024. Available from: https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/boletins\/epidemiologicos\/especiais\/2024\/boletim-epidemiologico-de-tuberculose-numero-especial-mar-2024.pdf\/view","DOI":"10.51161\/conasf2024\/33589"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34.        Dahl VN, M\u00f8lhave M, Fl\u00f8e A, Van Ingen J, Sch\u00f6n T, Lillebaek T, et al. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis. 2022;125:120-131. https:\/\/doi.org\/10.1016\/j.ijid.2022.10.013","DOI":"10.1016\/j.ijid.2022.10.013"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"35.        Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, et al. Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada. Chest. 2014;146(3):563-572. https:\/\/doi.org\/10.1378\/chest.13-2058","DOI":"10.1378\/chest.13-2058"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"36.        Winthrop K, Baxter R, Liu L, Varley C, Curtis J, Baddley J, et al. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis. 2013;72(1):37-42. https:\/\/doi.org\/10.1136\/annrheumdis-2011-200690","DOI":"10.1136\/annrheumdis-2011-200690"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"37.        Ashizawa H, Takazono T, Kawashiri SY, Nakada N, Ito Y, Ashizawa N, et al. Risk factor of non-tuberculous Mycobacterium infection in patients with rheumatoid arthritis and other autoimmune diseases receiving biologic agents: A multicenter retrospective study. Respir Investig. 2024;62(3):322-327. https:\/\/doi.org\/10.1016\/j.resinv.2024.02.005","DOI":"10.1016\/j.resinv.2024.02.005"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"38.        Verver S, Warren RM, Beyers N, Richardson M, Van Der Spuy GD, Borgdorff MW, et al. Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med. 2005;171(12):1430-1435. https:\/\/doi.org\/10.1164\/rccm.200409-1200OC","DOI":"10.1164\/rccm.200409-1200oc"}],"container-title":["Jornal Brasileiro de Pneumologia"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T21:59:03Z","timestamp":1731448743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jornaldepneumologia.com.br\/details\/4019\/en-US"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":38,"URL":"https:\/\/doi.org\/10.36416\/1806-3756\/e20240265","relation":{},"ISSN":["1806-3756"],"issn-type":[{"value":"1806-3756","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]}}}